Skip to content


Open Access

Erratum to: Making sense of big data in health research: towards an EU action plan

  • Charles Auffray1, 2Email author,
  • Rudi Balling3Email author,
  • Inês Barroso4,
  • László Bencze5,
  • Mikael Benson6,
  • Jay Bergeron7,
  • Enrique Bernal-Delgado8,
  • Niklas Blomberg9,
  • Christoph Bock10, 11, 12,
  • Ana Conesa13, 14,
  • Susanna Del Signore15,
  • Christophe Delogne16,
  • Peter Devilee17,
  • Alberto Di Meglio18,
  • Marinus Eijkemans19,
  • Paul Flicek20,
  • Norbert Graf21,
  • Vera Grimm22,
  • Henk-Jan Guchelaar23,
  • Yi-Ke Guo24,
  • Ivo Glynne Gut25,
  • Allan Hanbury26,
  • Shahid Hanif27,
  • Ralf-Dieter Hilgers28,
  • Ángel Honrado29,
  • D. Rod Hose30,
  • Jeanine Houwing-Duistermaat31,
  • Tim Hubbard32, 33,
  • Sophie Helen Janacek20,
  • Haralampos Karanikas34,
  • Tim Kievits35,
  • Manfred Kohler36,
  • Andreas Kremer37,
  • Jerry Lanfear38,
  • Thomas Lengauer12,
  • Edith Maes39,
  • Theo Meert40,
  • Werner Müller41,
  • Dörthe Nickel42,
  • Peter Oledzki43,
  • Bertrand Pedersen44,
  • Milan Petkovic45,
  • Konstantinos Pliakos46,
  • Magnus Rattray41,
  • Josep Redón i Màs47,
  • Reinhard Schneider3,
  • Thierry Sengstag48,
  • Xavier Serra-Picamal49,
  • Wouter Spek50,
  • Lea A. I. Vaas36,
  • Okker van Batenburg50,
  • Marc Vandelaer51,
  • Peter Varnai52,
  • Pablo Villoslada53,
  • Juan Antonio Vizcaíno20,
  • John Peter Mary Wubbe54 and
  • Gianluigi Zanetti55, 56
Genome Medicine20168:118

Received: 26 October 2016

Accepted: 26 October 2016

Published: 7 November 2016

The original article was published in Genome Medicine 2016 8:71


The published article [1] has two points of confusion in the section entitled “Technical challenges related to the management of electronic health records”. Firstly, the International Rare Diseases Research Consortium (IRDiRC) has developed policies and guidelines on approaches to data sharing meant to enable and improve the development of diagnoses and therapies for rare diseases. However, at present, IRDiRC has not developed best practices for the management of electronic health records (EHRs). Secondly, RARE-Bestpractices is a European Commission 7th Framework Programme (FP7) funded initiative, independent of IRDiRC. RARE-Bestpractices contributes to IRDiRC goals and objectives; however the initiative itself is not sponsored nor connected to IRDiRC.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

European Institute for Systems Biology and Medicine, Paris, France
CIRI-UMR5308, CNRS-ENS-INSERM-UCBL, Université de Lyon, Lyon, France
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
Wellcome Trust Sanger Institute, Cambridge, UK
Health Services Management Training Centre, Faculty of Health and Public Services, Semmelweis University, Budapest, Hungary
Centre for Personalised Medicine, Linköping University, Linköping, Sweden
Translational & Bioinformatics, Pfizer Inc., Cambridge, USA
Institute for Health Sciences, Zaragoza, Spain
ELIXIR, Cambridge, UK
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Max Planck Institute for Informatics, Saarbrücken, Germany
Príncipe Felipe Research Center, Valencia, Spain
University of Florida, Institute of Food and Agricultural Sciences (IFAS), Gainesville, USA
Bluecompanion Ltd, London, UK
Technology, Data & Analytics, KPMG Luxembourg, Société Coopérative, Luxembourg, Luxembourg
Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
Information Technology Department, European Organization for Nuclear Research (CERN), Geneva 23, Switzerland
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
Department of Pediatric Oncology/Hematology, Saarland University, Homburg, Germany
Project Management Jülich, Forschungszentrum Jülich GmbH, Jülich, Germany
Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands
Data Science Institute, Imperial College London, London, UK
CNAG-CRG, Center for Genomic Regulation, Barcelona Institute for Science and Technology (BIST), Barcelona, Spain
Institute of Software Technology and Interactive Systems, TU Wien, Vienna, Austria
The Association of the British Pharmaceutical Industry, London, UK
Department of Medical Statistics, RWTH-Aachen University, Universitätsklinikum Aachen, Aachen, Germany
SYNAPSE Research Management Partners, Barcelona, Spain
Department of Infection, Immunity and Cardiovascular Disease and Insigneo Institute for In-Silico Medicine, Medical School, University of Sheffield, Sheffield, UK
Department of Statistics, School of Mathematics, University of Leeds, Leeds, UK
Department of Medical & Molecular Genetics, London, UK
Genomics England, London, UK
National and Kapodistrian University of Athens, Medical School, Athens, Greece
Vitromics Healthcare Holding B.V., ’s-Hertogenbosch, The Netherlands
Fraunhofer Institute for Molecular Biology and Applied Ecology ScreeningPort, Hamburg, Germany
ITTM S.A., Esch-sur-Alzette, Luxembourg
Research Business Technology, Cambridge, UK
Health Economics & Outcomes Research, Diegem, Belgium
Janssen Pharmaceutica N.V., R&D G3O, Beerse, Belgium
Faculty of Life Sciences, University of Manchester, Manchester, UK
UMR3664 IC/CNRS, Institut Curie, Section Recherche, Pavillon Pasteur, Paris cedex 05, France
Linguamatics Ltd, Cambridge, UK
PwC Luxembourg, Luxembourg, Luxembourg
Philips, Eindhoven, The Netherlands
Department of Public Health and Primary Care, KU Leuven Kulak, Kortrijk, Belgium
INCLIVA Health Research Institute, University of Valencia, CIBERobn ISCIII, Valencia, Spain
Swiss Institute of Bioinformatics (SIB) and University of Basel, Basel, Switzerland
Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain
EuroBioForum Foundation, Vlaardingen, The Netherlands
Integrated BioBank of Luxembourg, Luxembourg, Luxembourg
Technopolis Group, Brighton, UK
Hospital Clinic of Barcelona, Institute d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain
European Platform for Patients’ Organisations, Science and Industry (Epposi), Brussels, Belgium
CRS4, Ed.1 POLARIS, Pula, Italy
BBMRI-ERIC, Graz, Austria


  1. Auffray C, Balling R, Barroso I, Bencze L, Benson M, Bergeron J, et al. Making sense of big data in health research: Towards an EU action plan. Genome Med. 2016;8:71.View ArticlePubMedPubMed CentralGoogle Scholar


© The Author(s). 2016